Is the business good?
How good a business is SION?
Sionna Therapeutics, Inc. earns −43% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
−43%
Return on invested capital · cost of capital 9.0% · 52 points below what the capital costs: growth destroys value
Details›
- Free cash flow, trailing twelve months
- −$76M
- Net income, trailing twelve months
- −$97M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- −43%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.